Aortic stiffness, kidney disease, and renal transplantation

  • Sola Aoun Bahous
  • Jacques Blacher
  • Michel E. SafarEmail author


In subjects with chronic kidney disease (CKD), treatment of high systolic blood pressure is a key element in preventing disease progression and the occurrence of cardiovascular (CV) events. This relationship between the large arterial system and kidney function was demonstrated in different renal populations. In subjects with mild to severe renal insufficiency, increased aortic stiffness and reduced creatinine clearance are closely related and are independent of traditional CV risk factors. In renal transplant patients, aortic stiffness is significantly increased irrespective of donor type. Donor age and/or acute rejection contribute independently to the increased stiffness. In the presence of renal dysfunction, an increase in systemic pulse pressure frequently may be observed and transmitted to the glomeruli. This alteration potentially initiates renal damage and favors CV events. In subjects with end-stage renal disease and high CV risk, pharmacologic modulation of the renin-angiotensin system might prevent CKD progression and CV events.


Chronic Kidney Disease Mean Arterial Pressure Arterial Stiffness Pulse Wave Velocity Chronic Kidney Disease Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References and Recommended Reading

  1. 1.
    Sarnak MJ, Levey AS, Schoolwerth AC, et al.: Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003, 42:1050–1065.PubMedCrossRefGoogle Scholar
  2. 2.
    Shlipak MG, Fried LF, Cushman M, et al.: Cardiovascular mortality risk in chronic kidney disease: comparison of traditional and novel risk factors. JAMA 2005, 293:1737–1745.PubMedCrossRefGoogle Scholar
  3. 3.
    Dahlof B, Devereux RB, Kjeldsen SE, et al.: Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002, 359:995–1003.PubMedCrossRefGoogle Scholar
  4. 4.
    Yusuf S, Sleight P, Pogue J, et al.: Effects of an angiotensinconverting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000, 342:145–153.PubMedCrossRefGoogle Scholar
  5. 5.
    Lewis EJ, Hunsicker LG, Clarke WR, et al.: Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001, 345:851–860.PubMedCrossRefGoogle Scholar
  6. 6.
    Jafar TH, Stark PC, Schmid CH, et al.: Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis. Ann Intern Med 2003, 139:244–252.PubMedGoogle Scholar
  7. 7.
    Youshauddin M, Bakris GL: The kidney and hypertension. In Hypertension, Principles and Practice. Edited by Battegay EJ, Lip GYH, Bakris GL. New York: Taylor & Francis; 2005:255–268.Google Scholar
  8. 8.
    Safar ME, Blacher J, Pannier B, et al.: Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002, 39:735–738.PubMedCrossRefGoogle Scholar
  9. 9.
    London GM, Guerin AP, Marchais SJ, et al.: Cardiac and arterial interactions in end-stage renal disease. Kidney Int 1996, 50:600–608.PubMedCrossRefGoogle Scholar
  10. 10.
    London GM, Guerin AP, Pannier B, et al.: Large artery structure and function in hypertension and end-stage renal disease. J Hypertens 1998, 16:1931–1938.PubMedCrossRefGoogle Scholar
  11. 11.
    Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998, 32:S112–S119.PubMedCrossRefGoogle Scholar
  12. 12.
    Toussaint ND, Lau KK, Strauss BJ, et al.: Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant 2008, 23:586–593.PubMedCrossRefGoogle Scholar
  13. 13.
    Blacher J, Guerin AP, Pannier B, et al.: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999, 99:2434–2439.PubMedGoogle Scholar
  14. 14.
    Guerin AP, Blacher J, Pannier B, et al.: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001, 103:987–992.PubMedGoogle Scholar
  15. 15.
    Mourad JJ, Girerd X, Boutouyrie P, et al.: Increased stiffness of radial artery wall material in end-stage renal disease. Hypertension 1997, 30:1425–1430.PubMedGoogle Scholar
  16. 16.
    Acar C, Jebara VA, Portoghese M, et al.: Comparative anatomy and histology of the radial artery and the internal thoracic artery. Implication for coronary artery bypass. Surg Radiol Anat 1991, 13:283–288.PubMedCrossRefGoogle Scholar
  17. 17.
    Amann K, Neususs R, Ritz E, et al.: Changes of vascular architecture independent of blood pressure in experimental uremia. Am J Hypertens 1995, 8:409–417.PubMedCrossRefGoogle Scholar
  18. 18.
    Amann K, Wolf B, Nichols C, et al.: Aortic changes in experimental renal failure: hyperplasia or hypertrophy of smooth muscle cells? Hypertension 1997, 29:770–775.PubMedGoogle Scholar
  19. 19.
    Mourad JJ, Pannier B, Blacher J, et al.: Creatinine clearance, pulse wave velocity, carotid compliance and essential hypertension. Kidney Int 2001, 59:1834–1841.PubMedCrossRefGoogle Scholar
  20. 20.
    Briet M, Bozec E, Laurent S, et al.: Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. Kidney Int 2006, 69:350–357.PubMedCrossRefGoogle Scholar
  21. 21.
    Gosse P, Safar ME: Arterial stiffness and plasma creatinine in untreated hypertensive patients. Am J Hypertens 2005, 18:1140–1145.PubMedCrossRefGoogle Scholar
  22. 22.
    Benetos A, Adamopoulos C, Bureau JM, et al.: Determinants of accelerated progression of arterial stiffness in normotensive subjects and in treated hypertensive subjects over a 6-year period. Circulation 2002, 105:1202–1207.PubMedCrossRefGoogle Scholar
  23. 23.
    Shanahan CM: Vascular calcification. Curr Opin Nephrol Hypertens 2005, 14:361–367.PubMedCrossRefGoogle Scholar
  24. 24.
    Blacher J, Guerin AP, Pannier B, et al.: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001, 38:938–942.PubMedCrossRefGoogle Scholar
  25. 25.
    Bahous SA, Stephan A, Barakat W, et al.: Aortic pulse wave velocity in renal transplant patients. Kidney Int 2004, 66:1486–1492.PubMedCrossRefGoogle Scholar
  26. 26.
    Bahous SA, Stephan A, Blacher J, Safar ME: Aortic stiffness, living donors, and renal transplantation. Hypertension 2006, 47:216–221.PubMedCrossRefGoogle Scholar
  27. 27.
    Covic A, Goldsmith DJ, Gusbeth-Tatomir P, et al.: Successful renal transplantation decreases aortic stiffness and increases vascular reactivity in dialysis patients. Transplantation 2003, 76:1573–1577.PubMedCrossRefGoogle Scholar
  28. 28.
    Kneifel M, Scholze A, Burkert A, et al.: Impaired renal allograft function is associated with increased arterial stiffness in renal transplant recipients. Am J Transplant 2006, 6:1624–1630.PubMedCrossRefGoogle Scholar
  29. 29.
    Zoungas S, Kerr PG, Chadban S, et al.: Arterial function after successful renal transplantation. Kidney Int 2004, 65:1882–1889.PubMedCrossRefGoogle Scholar
  30. 30.
    Delahousse M, Chaignon M, Mesnard L, et al.: Aortic stiffness of kidney transplant recipients correlates with donor age. J Am Soc Nephrol 2008, 19:798–805.PubMedCrossRefGoogle Scholar
  31. 31.
    Barenbrock M, Hausberg M, Kosch M, et al.: A longitudinal study of vessel wall properties in normotensive and hypertensive renal transplant recipients. J Hum Hypertens 1998, 12:707–711.PubMedCrossRefGoogle Scholar
  32. 32.
    Barenbrock M, Kosch M, Joster E, et al.: Reduced arterial distensibility is a predictor of cardiovascular disease in patients after renal transplantation. J Hypertens 2002, 20:79–84.PubMedCrossRefGoogle Scholar
  33. 33.
    Zethelius B, Berglund L, Sundström J, et al.: Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008; 358:2107–2116.PubMedCrossRefGoogle Scholar
  34. 34.
    Safar ME, London GM, Plante GE: Arterial stiffness and kidney function. Hypertension 2004, 43:163–168.PubMedCrossRefGoogle Scholar
  35. 35.
    Mitchell GF: Increased aortic stiffness: an unfavorable cardiorenal connection. Hypertension 2004, 43:151–153.PubMedCrossRefGoogle Scholar
  36. 36.
    London GM, Safar ME: Renal hemodynamics in patients with sustained essential hypertension and in patients with unilateral stenosis of the renal artery. Am J Hypertens 1989, 2:244–252.PubMedGoogle Scholar
  37. 37.
    Holstein-Rathlou NH, Marsh DJ: Renal blood flow regulation and arterial pressure fluctuations: a case study in nonlinear dynamics. Physiol Rev 1994, 74:637–681.PubMedGoogle Scholar
  38. 38.
    Hill GS, Heudes D, Jacquot C, et al.: Morphometric evidence for impairment of renal autoregulation in advanced essential hypertension. Kidney Int 2006, 69:823–831.PubMedCrossRefGoogle Scholar
  39. 39.
    Essig M, Terzi F, Burtin M, Friedlander G: Mechanical strains induced by tubular flow affect the phenotype of proximal tubular cells. Am J Physiol Renal Physiol 2001, 281:F751–F762.PubMedGoogle Scholar
  40. 40.
    Bidani AK, Griffin KA: Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension 2004, 44:595–601.PubMedCrossRefGoogle Scholar
  41. 41.
    Loutzenhiser R, Bidani A, Chilton L: Renal myogenic response: kinetic attributes and physiological role. Circ Res 2002, 90:1316–1324.PubMedCrossRefGoogle Scholar
  42. 42.
    Verhave JC, Fesler P, du Cailar G, et al.: Elevated pulse pressure is associated with low renal function in elderly patients with isolated systolic hypertension. Hypertension 2005, 45:586–591.PubMedCrossRefGoogle Scholar
  43. 43.
    Aoun S, Blacher J, Safar ME, Mourad JJ: Diabetes mellitus and renal failure: effects on large artery stiffness. J Hum Hypertens 2001, 15:693–700.PubMedCrossRefGoogle Scholar
  44. 44.
    Fehrman-Ekholm I, Elinder CG, Stenbeck M, et al.: Kidney donors live longer. Transplantation 1997, 64:976–978.PubMedCrossRefGoogle Scholar
  45. 45.
    Cortes P, Zhao X, Riser BL, Narins RG: Regulation of glomerular volume in normal and partially nephrectomized rats. Am J Physiol 1996, 270:F356–F370.PubMedGoogle Scholar
  46. 46.
    Safar ME: Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors. Curr Opin Nephrol Hypertens 2001, 10:257–261.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  • Sola Aoun Bahous
  • Jacques Blacher
  • Michel E. Safar
    • 1
    Email author
  1. 1.Diagnosis and Therapeutic CenterHôpital Hôtel-DieuParis Cedex 04France

Personalised recommendations